Arvinas (ARVN) Non-cash Items (2018 - 2021)
Arvinas (ARVN) recorded quarterly Non-cash Items of $210.3 million in Q3 2021, up 9583.42% quarter-over-quarter from $2.2 million in Q2 2021, and up 12118.71% on a YoY basis from N/an in Q3 2020.
Arvinas (ARVN) Non-cash Items (2018 - 2021) Analysis & Trends
Arvinas' Non-cash Items history runs 4 years deep, the most recent figure standing at $210.3 million for Q3 2021.
- In Q3 2021, Non-cash Items rose 12118.71% year-over-year to $210.3 million; the TTM figure through Sep 2021 stood at $210.3 million (up 12118.71% YoY), while the FY2020 annual figure was $253.2 million, up 25488.9% from the prior year.
- Non-cash Items was $210.3 million for Q3 2021 at Arvinas, up from $2.2 million in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $253.2 million in Q4 2020 to a low of $357658.0 in Q3 2018.
- Historically, Non-cash Items has averaged $48.9 million across 4 years, with a median of $1.3 million in 2020.
- The sharpest annual moves came in 2020 and 2021: Non-cash Items surged 25488.9% in 2020, then jumped 44.04% in 2021.
- A 4-year view of Non-cash Items shows it stood at $420087.0 in 2018, then jumped by 135.54% to $989465.0 in 2019, then soared by 25488.9% to $253.2 million in 2020, then dropped by 16.92% to $210.3 million in 2021.
- The last three Non-cash Items figures came in at $210.3 million (Q3 2021), $2.2 million (Q2 2021), and $161.9 million (Q1 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Arvinas | 492.16 Mn | -122.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 210.34 Mn |
| Sep 30, 2021 | 210.34 Mn |
| Jun 30, 2021 | 2.17 Mn |
| Jun 30, 2021 | 2.17 Mn |
| Mar 31, 2021 | 161.85 Mn |
| Mar 31, 2021 | 161.85 Mn |
| Dec 31, 2020 | 253.19 Mn |
| Dec 31, 2020 | 253.19 Mn |
| Sep 30, 2020 | 1.72 Mn |
| Sep 30, 2020 | 1.72 Mn |
| Jun 30, 2020 | 1.51 Mn |
| Jun 30, 2020 | 1.51 Mn |
| Mar 31, 2020 | 1.30 Mn |
| Mar 31, 2020 | 1.30 Mn |
| Dec 31, 2019 | 989,465.00 |
| Dec 31, 2019 | 989,465.00 |
| Sep 30, 2019 | 903,468.00 |
| Sep 30, 2019 | 903,468.00 |
| Jun 30, 2019 | 802,057.00 |
| Jun 30, 2019 | 802,057.00 |